Related Experiment Video
Updated: Aug 14, 2025

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Endoscopic balloon dilation management for benign duodenal stenosis
Vibhu Chittajallu1, Yazan Abu Omar2, C Roberto Simons-Linares3
1Digestive Health Institute, University Hospitals Cleveland, Cleveland, OH, USA. vibhu.chittajallu@uhhospitals.org.
Endoscopic balloon dilation (EBD) effectively treats benign duodenal stenosis (BDS) of various causes. Proton pump inhibitor (PPI) use independently predicts successful EBD outcomes, making it a low-risk initial treatment option.
Area of Science:
- Gastroenterology
- Endoscopy
- Surgical Research
Background:
- Benign duodenal stenosis (BDS) is frequently caused by peptic ulcer disease (PUD).
- Endoscopic balloon dilation (EBD) is the standard initial treatment for BDS.
- Limited literature supports EBD's efficacy for BDS.
Purpose of the Study:
- To investigate the spectrum of causes for benign duodenal stenosis.
- To evaluate the effectiveness of endoscopic balloon dilation for BDS.
- To compare outcomes of EBD for different etiologies of BDS.
Main Methods:
- A cohort study analyzed 86 patients with BDS undergoing EBD between 2002 and 2018.
- Data were collected from a prospectively maintained database at a tertiary academic center.
- Technical and clinical success rates of EBD were compared across etiologies and patient demographics.
Main Results:
- Peptic ulcer disease (PUD) was the most common cause (45.3%), followed by Crohn's disease (22.1%) and idiopathic causes (26.7%).
- Technical success rate was 97.4% and clinical success rate was 77.8% for index dilations.
- Proton pump inhibitor (PPI) usage was associated with a 3.6-fold increase in clinical success (p=0.04).
Conclusions:
- Endoscopic balloon dilation (EBD) demonstrates high technical and clinical success for benign duodenal stenosis (BDS), irrespective of etiology.
- EBD is a low-risk alternative to surgical intervention for initial BDS management.
- Proton pump inhibitor (PPI) use is an independent predictor of clinical success in EBD for BDS.
More Related Videos
Related Concept Videos
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Endoscopic Procedures V: ERCP
Patient...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

